EMJD

Erasmus Mundus Joint Doctorate Program

Objective

Erasmus Mundus Joint Doctorate Programme is a cooperation and mobility programme funded by the Education, Culture and Audiovisual Executive Agency (EACEA) of the European Commission in the field of higher education for:

  • the enhancement of quality in European higher education;
  • the promotion of the European Union as a centre of excellence in learning around the world;
  • the promotion of intercultural understanding through cooperation with third countries as well as for the development of third countries in the field of higher education.

The programme enables PhD students to get a double degree, from two different partner institutes of the consortium (see partners involved in the project)

The studies conducted within the current programme will contribute to improved access to care and prevention; quality health services to ensure better health outcomes; innovative care constellations that build on patient/community engagement as well as public-private partnerships; and re-orientation of the current global health emphasis on infectious diseases by incorporating the challenges of non-communicable diseases and ageing. Integrated and effective global health solutions will be realised through synergistic, transdisciplinary and evidence-based research.

Background

AIGHD is currently hosting 4 PhD students within this program:

  • Willy Ssengooba from Uganda is completing his PhD from 2013-2016. His PhD is titled: “Consequences of Mycobacterium tuberculosis genetic diversity in the context of HIV co-infection for laboratory diagnosis of tuberculosis in Africa”
  • Seth Inzaule from Kenia is completing his PhD from 2014-2017. His PhD is titled: “Towards successful long-term antiretroviral treatment in sub-Saharan Africa: outcomes, determinants and diagnostics
  • Alberto Lopez Garcia-Basteiro from Spain is completing his PhD from 2015-2018. His PhD is titled: “Towards improving TB mortality estimates in Mozambique”
  • Gertrude Nsorma Nyaaba from Ghana is completing her PhD from 2015 – 2018). Her PhD is titled: “Improving hypertension control among sub-Saharan Africans: the case of Ghanaians”

Summary

Name: EMJD
Status: Start: September, 2013
End: August, 2020
Principal Investigator: Prof. F. Cobelens and Prof T. Rinke de Wit
Departments(s): AIGHD
Partners: VU University Amsterdam (Netherlands)

University of Amsterdam (Netherlands)

Academic Medical Centre at the University of Amsterdam (Netherlands)

Université de Bordeaux (France)

Institute of Tropical Medicine Antwerp (Belgium)

University of Barcelona Institute for Global Health (Spain)

Contact information: Marloes Nijboer, project manager (m.nijboer@aighd.org)
Duration: Initiated
Funded by: The Education, Culture and Audiovisual Executive Agency (EACEA) of the European Commission.
Countries: Spain, Belgium, Mozambique, Kenia, Ghana, and the Netherlands
Publications: Willy Ssengooba (PhD: 2013-2016) “Consequences of Mycobacterium tuberculosis genetic diversity in the context of HIV co-infection for laboratory diagnosis of tuberculosis in Africa”

 

  • Ssengooba W, de Jong, C. Bouke. Joloba, L. Moses. Cobelens, G. Frank. Meehan, J. Conor.: Whole genome sequencing reveals mycobacterial microevolution among concurrent isolates from sputum and blood in HIV infected TB patients. In press, BMC infectious diseases 2016.
  • Ssengooba W, Meehan CJ, Lukoye D, Kasule GW, Musisi K, Joloba ML, Cobelens FG, de Jong BC: Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda. Infect Genet Evol 2016. URL http://www.ncbi.nlm.nih.gov/pubmed/26917365
  • Ssengooba W, Cobelens FG, Nakiyingi L, Mboowa G, Armstrong DT, Manabe YC, Joloba ML, de Jong BC: High Genotypic Discordance of Concurrent Mycobacterium tuberculosis Isolates from Sputum and Blood of HIV-Infected Individuals. PloS one 2015, 10(7):e0132581. URL: http://www.ncbi.nlm.nih.gov/pubmed/26176604
  • Nakiyingi L, Ssengooba W, Nakanjako D, Armstrong D, Holshouser M, Kirenga BJ, Shah M, Mayanja-Kizza H, Joloba ML, Ellner JJ et al: Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda. BMC infectious diseases 2015, 15(1):812. http://www.ncbi.nlm.nih.gov/pubmed/25888317
  • Ssengooba W, Nakiyingi L, Armstrong DT, Cobelens FG, Alland D, Manabe YC, Dorman SE, Ellner JJ, Joloba ML: Clinical Utility of a Novel Molecular Assay in Various Combination Strategies with Existing Methods for Diagnosis of HIV-Related Tuberculosis in Uganda. PloS one 2014, 9(9):e107595. URL http://www.ncbi.nlm.nih.gov/pubmed/25222866

Alberto Lopez Garcia-Basteiro (PhD: 2015-2018) “Towards improving TB mortality estimates in Mozambique”

 

  • García-Basteiro AL, Respeito D, Augusto OJ, López-Varela E, Sacoor C, Sequera VG, Casellas A, Bassat Q, Manhiça I, Macete E, Cobelens F, Alonso PL. Poor tuberculosis treatment outcomes in Southern Mozambique (2011-2012). BMC Infect Dis. 2016 May 20;16(1):214
  • García-Basteiro AL, Ruhwald M, Lange C Design of tuberculosis vaccine trials under financial constraints. Expert Rev Vaccines. 2016 Jul;15(7):799-801.
  • Vilajeliu A, Sequera VG, García-Basteiro AL, Sicuri E, Aldea M, Velasco C, Bayas JM. Immunogenicity and immunization costs of adjuvanted versus non-adjuvanted hepatitis B vaccine in chronic kidney disease patients. Hum Vaccin Immunother. 2016 In press
  • Garcia-Basteiro AL, Mamudo I, Carrilho C, Ussene E, Castillo P, Chitsungo D, Rodríguez C, Lovane L, Vergara A, Lorenzoni C, Ordi J, Menéndez C, Bassat Q, Martínez MJ. The role of Xpert MTB/RIF in diagnosing pulmonary tuberculosis in post-mortem tissues. Sci Rep. 2016 Feb 10;6:20703.
  • López-Varela, E, Augusto OJ, Guerra L, Respeito D, Sacoor C, Sacarlal J, Migliori GB, Sotgiu G,  Alonso PL, García-Basteiro, AL. Low pediatric Case Detection Rate in Southern Mozambique. Eur Respir J. 2016;47(3):1003-5

See the Trans Global Health website for more information.